2025-04-17 IDOPRESS
HANGZHOU,China,April 15,2025 -- NetEase,Inc.(NASDAQ: NTES and HKEX: 9999,"NetEase" or "the Company"),a leading internet and game services provider,today announced that it filed its annual report on Form 20-F for the fiscal year endedDecember 31,2024. The annual report can be accessed on the Company's investor relations website athttp://ir.netease.com/.
The Company will provide a hard copy of its annual report containing the audited consolidated financial statements,free of charge,to its shareholders and ADS holders upon request. Requests should be directed to theIR Department,NetEase,Inc.,NetEase Building,No.399Wangshang Road,Binjiang District,Hangzhou,310052,People's Republic of Chinaat the contact information listed below.
AboutNetEase,Inc.
NetEase,Inc. (NASDAQ: NTES and HKEX: 9999,"NetEase") is a leading internet and game services provider centered around premium content. With extensive offerings across its expanding gaming ecosystem,the Company develops and operates some of the most popular and longest running mobile and PC games available in China and globally.
Powered by one of the largest in-house game R&D teams focused on mobile,PC and console,NetEase creates superior gaming experiences,inspires players,and passionately delivers value for its thriving community worldwide. By infusing play with culture,and education with technology,NetEase transforms gaming into a meaningful vehicle to build a more entertaining and enlightened world.
Beyond games,NetEase service offerings include its majority-controlled subsidiaries Youdao (NYSE: DAO),an intelligent learning and advertising solutions provider,and NetEase Cloud Music (HKEX: 9899),a well-known online music platform featuring a vibrant content community,as well as Yanxuan,NetEase's private label consumer lifestyle brand.
For more information,please visit: http://ir.netease.com/.
Contact for Media and Investors:
Investor Relations
Email:ir@service.netease.com
Tel: (+86) 571-8985-3378
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Diet Tips Daily